19.93

4.68% -0.9169

Aligos Therapeutics Inc (ALGS)

Overview News Price History Option Chain Financials Why ALGS Down? Discussions Forecast

Aligos Therapeutics Inc stock is traded at $19.93, with a volume of 149.20K. It is down -4.68% in the last 24 hours and down -41.18% over the past month. Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Previous Close:

$20.85

Open:

$21.47

24h Volume:

149.20K

Relative Volume:

0.39

Market Cap:

$74.81M

Revenue:

$7.97M

Net Income/Loss:

$-75.74M

P/E Ratio:

-0.8208

EPS:

-24.2853

Net Cash Flow:

$-85.33M

1W Performance:

-16.03%

1M Performance:

-41.18%

6M Performance:

+44.55%

1Y Performance:

+19.37%

1-Day Range:

$19.65

$21.88

1-Week Range:

$19.65

$24.32

52-Week Range:

$6.76

$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name

Aligos Therapeutics Inc

Sector

Healthcare (1174)

Industry

Biotechnology (677)

Phone

(800) 466-6059

Address

ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

ALGS's Discussions on Twitter

Compare ALGS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALGS Aligos Therapeutics Inc	19.88	74.81M	7.97M	-75.74M	-85.33M	-24.29
VRTX Vertex Pharmaceuticals Inc	485.99	123.34B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	699.39	76.09B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	649.88	39.34B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	249.69	32.49B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	122.49	28.26B	3.30B	-501.07M	1.03B	-2.1146

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-19-24	Initiated	H.C. Wainwright	Buy
Jan-06-23	Upgrade	Jefferies	Hold → Buy
Jan-06-23	Upgrade	Piper Sandler	Neutral → Overweight
Mar-23-22	Downgrade	Piper Sandler	Overweight → Neutral
Jan-07-22	Downgrade	JP Morgan	Overweight → Neutral
Jan-06-22	Downgrade	Jefferies	Buy → Hold
Sep-09-21	Initiated	SVB Leerink	Outperform
May-17-21	Resumed	Piper Sandler	Overweight
Nov-10-20	Initiated	Cantor Fitzgerald	Overweight
Nov-10-20	Initiated	JP Morgan	Overweight
Nov-10-20	Initiated	Jefferies	Buy
Nov-10-20	Initiated	Piper Sandler	Overweight

View All

Aligos Therapeutics Inc Stock (ALGS) Latest News

Feb 19, 2025

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Significant Decline in Short Interest - MarketBeat

Feb 19, 2025

Aligos Therapeutics looks to raise $105 million in private placement - MSN

Feb 19, 2025

Feb 17, 2025

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Down 13.2% in January - Defense World

Feb 17, 2025

Feb 14, 2025

Aligos Therapeutics Announces $105 Million Private Placement FinancingAligos Therapeutics, Inc. (NASDAQ: ALGS) recently disclosed a Securities Purchase Agreement engagement entailing a Private Placement offering. The agreement includes the issuan - Defense World

Feb 14, 2025

Feb 12, 2025

Aligos Therapeutics, Inc. announced that it expects to receive $105.003206 million in funding - Marketscreener.com

Feb 12, 2025

Aligos Therapeutics secures $105 million in private placement By Investing.com - Investing.com Canada

Feb 12, 2025

Aligos Therapeutics Announces $105 Million Private Placement Financing - The Bakersfield Californian

Feb 12, 2025

Trading (ALGS) With Integrated Risk Controls - Stock Traders Daily

Feb 12, 2025

Feb 08, 2025

Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely - Yahoo Canada Finance

Feb 08, 2025

Feb 04, 2025

Aligos Therapeutics patents new inhibitors of PD-1, PD-L1 or PD-1/PD-L1 interaction - BioWorld Online

Feb 04, 2025

PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last? - Yahoo Finance

Feb 04, 2025

Feb 03, 2025

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Update - MarketBeat

Feb 03, 2025

Aligos Therapeutics Appoints Lesley Ann Calhoun as COO - TipRanks

Feb 03, 2025

Jan 31, 2025

(ALGS) On The My Stocks Page - Stock Traders Daily

Jan 31, 2025

Jan 27, 2025

Drive Wealth Management LLC Takes $916,000 Position in Aligos Therapeutics, Inc. (NASDAQ:ALGS) - MarketBeat

Jan 27, 2025

Jan 21, 2025

Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) market cap surged US$16m last week, retail investors who have a lot riding on the company were rewarded - Simply Wall St

Jan 21, 2025

When the Price of (ALGS) Talks, People Listen - Stock Traders Daily

Jan 21, 2025

Jan 20, 2025